AP-325 in Subjects With Peripheral Post-surgical Neuropathic Pain

NCT04429919 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Post-surgical Neuropathic Pain

Interventions

DRUG: AP-325
DRUG: Placebo

Sponsor

Algiax Pharmaceuticals GmbH

Collaborators

[object Object]